Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0)

Szigeti, 2006, Charcot–Marie–Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management, Genet Med, 8, 86, 10.1097/01.gim.0000200160.29385.73 Hayasaka, 1993, De novo mutation of the myelin P0 gene in Dejerine–Sottas disease (hereditary motor and sensory neuropathy type III), Nat Genet, 5, 266, 10.1038/ng1193-266 Floroskufi, 2007, New mutation of the MPZ gene in a family with the Dejerine–Sottas disease phenotype, Muscle Nerve, 35, 667, 10.1002/mus.20703 Shy, 2004, Phenotypic clustering in MPZ mutations, Brain, 127, 371, 10.1093/brain/awh048 Maki, 1999, MR imaging of Dejerine–Sottas disease, AJNR Am J Neuroradiol, 20, 378 Inoue, 2004, Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations, Nat Genet, 36, 361, 10.1038/ng1322 Gaboreanu, 2007, Myelin protein zero/P0 phosphorylation and function require an adaptor protein linking it to RACK1 and PKC alpha, J Cell Biol, 177, 707, 10.1083/jcb.200608060 Filbin, 1990, Role of myelin P0 protein as a homophilic adhesion molecule, Nature, 344, 871, 10.1038/344871a0 Filbin, 1993, Homophilic adhesion of the myelin P0 protein requires glycosylation of both molecules in the homophilic pair, J Cell Biol, 122, 451, 10.1083/jcb.122.2.451 Xu, 2001, Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination, J Cell Biol, 155, 439, 10.1083/jcb.200107114 Khajavi, 2005, Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants, Am J Hum Genet, 77, 841, 10.1086/497541 Pennuto, 2008, Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot–Marie–Tooth 1B mice, Neuron, 57, 393, 10.1016/j.neuron.2007.12.021